Platform
Features
0 followers
Renalytix (LSE: RENX) (NASDAQ: RNLX) is the founder and global leader in the new field of bioprognosis™ for kidney health.
Industries
Headquarters
Employees
Links
James McCullough
14 members
8 members
3 members
4 members
Kura Oncology
17 followers
Kymera Therapeutics
5 followers
SpringWorks Therapeutics
4 followers
Biofourmis
Owkin
Immunovant
ACROBiosystems
2 followers
Gene by Gene
Dragonfly Therapeutics
1 follower
Passage Bio
Invivyd
Discover companies